Unichem Laboratories has received ANDA approval from the United States Food and Administration (USFDA) for Tizanidine Tablets. Tizanidine tablets USP 2mg and 4mg are therapeutically equivalent to ZANAFlEX tablets 2mg and 4mg from Acorda Therapeutics. Tizanidine tablets belong to a group of medicines called skeletal muscle relaxants. Tizanidine tablets is used to help relieve, although not cure, muscle spasms caused by medical conditions such as multiple sclerosis or injuries to the brain or spine.
Further, the product will be commercialized from Unichem’s Goa plant. Further, active pharmaceutical ingredient i.e., Tizanidine Hydrochloride used for this ANDA is also made in-house at Roha plant.
Currently, there are 9 generic approvals, while only 3 companies are dominating the market. The current market size is $70 million growing at 5% in value terms and 10% in volume.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: